|
Mr. Geffken has more than 25 years of financial management experience. He has been the chief financial officer of six companies, ranging from venture-backed start-ups to publicly-held corporations. Mr. Geffken played a critical role in building infrastructure, managing fundraising and investor relations, and leading finance organizations in several high growth life science companies, including Transkaryotic Therapies, Inc. (later acquired by Shire plc), CytoTherapeutics, Inc., and Omnisonics Medical Technologies, Inc. During his career, he has raised more than $700 million in debt and equity financings. He joined Codon Devices from Konarka Technologies, Inc., where he was Executive Vice President and Chief Financial Officer. Mr. Geffken has a B.S. in Economics from The Wharton School, University of Pennsylvania, and an MBA from Harvard Business School. | 